1. Home
  2. ELVN vs PDM Comparison

ELVN vs PDM Comparison

Compare ELVN & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • PDM
  • Stock Information
  • Founded
  • ELVN 2016
  • PDM 1997
  • Country
  • ELVN United States
  • PDM United States
  • Employees
  • ELVN N/A
  • PDM N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • PDM Building operators
  • Sector
  • ELVN Health Care
  • PDM Real Estate
  • Exchange
  • ELVN Nasdaq
  • PDM Nasdaq
  • Market Cap
  • ELVN 1.2B
  • PDM 921.9M
  • IPO Year
  • ELVN 2020
  • PDM N/A
  • Fundamental
  • Price
  • ELVN $22.63
  • PDM $7.61
  • Analyst Decision
  • ELVN Strong Buy
  • PDM Buy
  • Analyst Count
  • ELVN 5
  • PDM 5
  • Target Price
  • ELVN $41.20
  • PDM $9.40
  • AVG Volume (30 Days)
  • ELVN 721.5K
  • PDM 972.7K
  • Earning Date
  • ELVN 08-12-2025
  • PDM 07-28-2025
  • Dividend Yield
  • ELVN N/A
  • PDM 6.57%
  • EPS Growth
  • ELVN N/A
  • PDM N/A
  • EPS
  • ELVN N/A
  • PDM N/A
  • Revenue
  • ELVN N/A
  • PDM $568,472,000.00
  • Revenue This Year
  • ELVN N/A
  • PDM $0.50
  • Revenue Next Year
  • ELVN N/A
  • PDM N/A
  • P/E Ratio
  • ELVN N/A
  • PDM N/A
  • Revenue Growth
  • ELVN N/A
  • PDM N/A
  • 52 Week Low
  • ELVN $13.30
  • PDM $5.46
  • 52 Week High
  • ELVN $30.03
  • PDM $11.12
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 60.45
  • PDM 59.27
  • Support Level
  • ELVN $19.38
  • PDM $7.33
  • Resistance Level
  • ELVN $21.34
  • PDM $7.71
  • Average True Range (ATR)
  • ELVN 1.27
  • PDM 0.22
  • MACD
  • ELVN 0.11
  • PDM 0.01
  • Stochastic Oscillator
  • ELVN 88.47
  • PDM 84.38

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About PDM Piedmont Office Realty Trust Inc.

Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.

Share on Social Networks: